Some research protocols start at 2mg daily for the first week before increasing to the target dose
Whats the actual difference in results between 0.04 mg and 0.1 mg per injection site
There were no statistically significant differences in age between the groups initially diagnosed with or without VCD, as indicated in Table 1
injectable provides systemic effects beyond skin including potential joint, gut, and systemic anti-inflammatory research applications
(11) P Dick, C Costa, K Fayolle, M E Grandjean, A Khoshbeen, and R Tissot (1984) DSIP in the treatment of withdrawal syndromes from alcohol and opiates European Neurology, 1984, Volume 23 (Issue 5), Pages 364-71
Dosing Phases & Cycling The KLOW research protocol is built as three descending-frequency phases plus an on/off cycle